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Abstract
We have investigated the effect of advanced glycation end products (AGEs) on the crosslinking of collagen. The potential
pathological significance of AGEs and the altered metabolism of ascorbic acid (ASA) in diabetes have prompted us to
investigate the role of ASA in the crosslinking and advanced glycation of collagen. Rat tail tendons were incubated with ASA
and dehydroascorbic acid (DHA) under physiological conditions of temperature and pH, and the crosslinking and the level
of AGEs were analyzed. Analysis of crosslinking was conducted by pepsin solubility and cyanogen bromide digestion. Level
of AGEs was estimated by enzyme-linked immunosorbent assay (ELISA) using antibodies raised against AGE-ribonuclease.
It was noted that ASA and DHA induced crosslinking of collagen and stimulated the formation of AGEs. It was also noted
that these pathways were dependent on oxidative conditions. Similarly incubation of collagen with AGEs, prepared by the in
vitro incubation of bovine serum albumin (BSA) with glucose, also resulted in increased crosslinking. The extent of
crosslinking was dependent on the duration of incubation. The novel finding of this study, which is in contrast to the earlier
reports on glucose-induced crosslinking of collagen, was that AGEs-induced crosslinking of collagen was not inhibited by
radical scavengers and the metal chelator, EDTA, whereas glucose-induced crosslinking of collagen was almost completely
prevented by free radical scavengers. The increased fluorescence intensity observed in collagen incubated with AGEs was also
not prevented by radical scavengers. Estimation of AGEs by ELISA revealed an increased accumulation of AGEs in collagen
incubated with AGE-BSA. The inhibitory effect of aminoguanidine and aspirin on AGEs-induced modification of collagen,
strongly suggests that the amino-carbonyl interaction between AGEs and collagen may play a key role in the crosslinking
process. The results obtained in this study indicate that soluble AGEs can directly induce crosslinking of collagen and this
process is independent of oxidative conditions. From these results it may be hypothesized that glucose, under oxidative
conditions, reacts with proteins to form potentially reactive end products called AGEs. These AGEs, once formed, could
induce crosslinking of collagen even in the absence of both glucose and oxygen. ß 1998 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Experimental evidences indicate that collagen in
diabetes undergoes extensive chemical modi¢cations
that result in decreased solubility, decreased suscept-
ibility to enzymes, increased stability, accelerated
crosslinking and increased browning [1^4]. These
modi¢cations of collagen have received considerable
attention, since collagen is an important constituent
of most of the tissues that are damaged in diabetes.
Modi¢cation of this major extracellular matrix pro-
tein is directly involved in the pathogenesis of dia-
betic complications [5^7]. Although an association
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between increased collagen crosslinking and the de-
velopment of diabetic complications has been widely
recognized, a clear understanding of the mechanisms
involved in the accelerated crosslinking of collagen is
still lacking [8]. A broad spectrum of compounds like
aminoguanidine, cyclooxygenase and lipoxygenase
inhibitors, penicillamine, antioxidants, etc. [9^12]
with di¡erent mechanisms of action have been shown
to inhibit crosslinking of collagen in diabetes. These
observations raise speculations on the biochemical
mechanism of collagen crosslinking in diabetes. An
understanding of the mechanism of collagen cross-
linking in diabetes may help in the development of
pharmacological agents that could ameliorate the se-
verity of diabetic complications.
Among the various theories proposed to explain
the accelerated crosslinking of collagen in diabetes,
glycation has received considerable interest in the
recent years. Prolonged incubation of collagen with
excess glucose results in increased crosslinking and
browning, similar to that observed in diabetic colla-
gen [13,14]. However the molecular mechanism in-
volved in glucose-induced crosslinking of collagen
is not completely divulged. Previously it was believed
that glucose binds to the free amino group of colla-
gen followed by slow rearrangements that ¢nally re-
sult in intra- or intermolecular crosslinks. Recent ex-
periments have shown that oxidation and free
radicals are the major mediators of glucose-induced
crosslinking of collagen [15,16]. Reactive oxygen spe-
cies acts as a ¢xative that couples both glycation and
crosslinking of collagen. In vitro experiments have
demonstrated that the incubation of collagen with
glucose under antioxidative conditions results in the
complete inhibition of collagen crosslinking and
browning. Although the critical role of oxidation re-
actions in glucose-induced crosslinking of collagen is
widely recognized, the sequence of reactions, glyca-
tion versus oxidation is not properly understood.
The discovery that the accelerated crosslinking of
collagen is frequently accompanied by an increased
accumulation of AGEs has resulted in the assump-
tion that AGEs are involved in collagen crosslinking.
However, the biochemical mechanisms involved are
still uncertain.
Recent experimental evidences indicate a potential
role for ascorbic acid (ASA) in Maillard reaction
[17]. Pentosidine and carboxymethyllysine (CML),
the structurally characterized AGEs, have been
shown to form from the chemical reaction between
ASA and proteins [18,19]. In addition, it was dem-
onstrated that the physicochemical changes observed
in the cataractous lenses of diabetic and aged pa-
tients could be duplicated by the incubation of native
lens crystallins with ASA [17,20]. Although consider-
able e¡orts have been taken to understand the sig-
ni¢cance of ASA in the pathogenesis of cataract, not
much is known about the role of ASA in the cross-
linking of the structural protein, collagen. In this
study attention is focused on the role of ASA in
the crosslinking of collagen.
The purpose of the present work is to gain an in-
sight into the relationship between AGEs and colla-
gen crosslinking. It is well known that the concen-
tration of AGE peptides is increased in diabetes
[21,22]. This study was undertaken mainly to inves-
tigate whether AGEs can directly induce collagen
crosslinking. The signi¢cance of oxidation reactions
in this process was also studied. The work for the
¢rst time presents direct evidence for the involvement
of AGEs in collagen crosslinking and also indicates
AGEs as the cause of collagen crosslinking in diabe-
tes.
2. Materials and methods
2.1. Materials
Bovine serum albumin (BSA), catalase (from bo-
vine liver 2000^5000 units/mg protein), cyanogen
bromide, ASA, pepsin, glutathione, collagenase
(type VII), hydroxyproline, aminoguanidine, ribonu-
clease (RNase), peroxidase-conjugated anti-rabbit
IgG, aspirin and o-phenylenediamine were obtained
from Sigma Chemical Company (St. Louis, USA).
Ethylene diamine tetra acetic acid (EDTA), sodium
benzoate, and mannitol were purchased from S.D.
Fine Chemicals Limited (Mumbai, India). Phos-
phate-bu¡ered saline (PBS) in solid form was pur-
chased from Hi-media Laboratories (Mumbai, In-
dia). All other solvents and reagents used were of
highest analytical grade. Bu¡ers and reagents used
for the experiments were prepared in double distilled,
deionized, ¢lter sterilized water (0.2 W) unless other-
wise indicated.
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2.2. Incubations
Rat tail tendons were obtained from male Wistar
rats weighing about 200^250 g. The animals were
killed under ether anesthesia, the tail tendons re-
moved and washed thoroughly in physiological saline
at 4‡C. Washed tendons were cut into approximately
5 cm long segments and used for the incubations.
Incubations were conducted in 0.2 M phosphate buf-
fer pH 7.4 at 37‡C in the dark. The samples were
incubated in screw-capped scintillation vials and kept
for shaking (50 rpm). About 100 mg (wet weight)
tendons were incubated in 10 ml of PBS containing
AGE-BSA at a concentration of 1 mg/ml. ASA (20
mM) and dehydroascorbic acid (DHA) (20 mM)
were freshly prepared and added from a concen-
trated stock solution. Radical scavengers like manni-
tol (100 mM), sodium benzoate (100 mM), catalase
(25 Wg/ml), EDTA (2/5 mM) and the antiglycating
agents such as aminoguanidine (20/50 mM) and as-
pirin (20 mM) were all added from concentrated
stock solutions.
2.3. Preparation of AGEs
AGE-BSA was prepared by incubating BSA (50
mg/ml) with 0.5 M glucose in 0.2 M phosphate bu¡er
pH 7.4 for 3 months. The sample was then exten-
sively dialyzed to remove all the unbound glucose.
After complete dialysis the sample was re-incubated
for another 3 months to ensure maximum formation
of AGEs. A few drops of toluene were included to
prevent microbial growth. After 6 months the sample
turned dark brown in color. The formation of AGEs
was con¢rmed by enzyme-linked immunosorbent as-
say (ELISA) using antibodies raised against AGE-
ribonuclease (AGE-RNase).
2.4. Analysis of crosslinking of collagen
The crosslinking of collagen was evaluated by an-
alyzing cyanogen bromide peptides by sodium dodec-
yl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and measuring changes in solubilization of
tendons by limited pepsin digestion as described by
Fu et al. [16].
Cyanogen bromide digestion of collagen samples
was conducted as described by Brownlee et al. [9].
After complete dialysis electrophoretic analysis was
conducted as described by Laemmli [23].
Limited pepsin digestion was conducted by treat-
ing about 3.0 mg collagen with pepsin (20 Wg pepsin/
mg collagen) for 3 h in 0.5 ml of 0.5 M acetic acid at
37‡C in a shaking waterbath. The samples were then
centrifuged and the amount of hydroxyproline in the
supernatant and the pellet was estimated [24] and the
solubility criteria were expressed as percentage.
2.5. Measurement of £uorescence
Fluorescence was measured by the method de-
scribed by Monnier et al. [25]. Collagenase digested
samples were tested for £uorescence intensity at ex:
370 nm/em: 440 nm in a Hitachi F-4000 spectro-
£uorimeter.
2.6. Antigen preparation and immunization
AGE-RNase prepared by incubating RNase (20
mg/ml) with 0.5 M glucose in 0.2 M phosphate bu¡er
(pH 7.4) for 3 months was used as the antigen for
immunization. Two female white rabbits were immu-
nized by subcutaneous administration of 100 Wg
AGE-RNase in Freund’s complete adjuvant. This
was followed by four booster doses in incomplete
adjuvant. Antibody response was checked by Ouch-
terlony double di¡usion and non-competitive ELI-
SA.
2.7. Competitive ELISA for AGEs
Test samples for ELISA were prepared as follows.
Immediately after the incubation period, tail tendons
were thoroughly washed to remove all the unbound
materials. The samples were then digested by colla-
genase (type VII) (1:50) for 48 h at 37‡C, centrifuged
and the supernatant was used for the assay. Hy-
droxyproline estimation of the supernatant was car-
ried out as described by Woessner [24].
AGEs measurements were performed by competi-
tive ELISA as described by Makita et al. [26] with a
few modi¢cations. AGE-BSA prepared by incubating
BSA (50 mg/ml) with 0.5 M glucose in 0.2 M phos-
phate bu¡er pH 7.4 for 6 months was used as the
standard. In order to minimize background readings,
antibodies raised against AGE-RNase was used to
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detect AGE-collagen, using AGE-BSA as standard.
This procedure ensures that the absorbance obtained
is almost completely due to AGE antibody-antigen
reaction.
96 well microtiter plates were coated with AGE-
BSA by adding 0.1 ml solution of AGE-BSA (10 Wg/
ml) to each well and incubated overnight at 4‡C.
Wells were washed three times with PBS containing
0.1% Tween 20 (PBS-Tween). Wells were then
blocked by incubation for 1 h with 0.1 ml of 0.5%
gelatin. After washing three times with PBS-Tween,
0.1 ml of antisera (1:2000) pre-incubated overnight
at 4‡C with either the standard or test antigen was
added and incubated for 2 h at 37‡C. Wells were
then washed three times with PBS-Tween and devel-
oped with peroxidase-conjugated anti-rabbit IgG uti-
lizing o-phenylenediamine as the substrate. Absorb-
ance was measured at 492 nm in a computerized
ELISA reader (Bio-Rad, USA). The results were ex-
pressed as AGEs unit. The absorbance correspond-
ing to 1 Wg AGE-BSA standard was arbitrarily ¢xed
as one AGEs unit.
3. Results
The extent of crosslinking of collagen was ana-
lyzed by pepsin solubility and cyanogen bromide
peptide mapping. Figs. 1 and 2 show the e¡ect of
ASA and DHA on pepsin solubility of collagen. It
was observed that the incubation of tail tendon col-
lagen with 20 mM ASA for 4 weeks resulted in 68%
reduction in pepsin solubility compared to control.
ASA-induced pepsin insolubility was signi¢cantly
prevented by free radical scavengers. Among the rad-
ical scavengers tested glutathione was found to be
highly e¡ective. Aminoguanidine, an advanced glyca-
tion inhibitor, and EDTA, a metal chelator, also
showed almost complete inhibition. Similar results
were obtained with DHA incubated collagen. How-
ever, the inhibitory e¡ect of free radical scavengers
was not as e⁄cient as observed in the samples incu-
bated with ASA. Benzoate, mannitol and EDTA
showed more than 60% inhibition of pepsin insolu-
bility of collagen samples incubated with ASA,
whereas in the DHA incubated samples these radical
scavengers showed less than 40% inhibition. The in-
hibitory e¡ect of glutathione was also reduced in
DHA incubated samples. These results were further
con¢rmed by the cyanogen bromide digestion studies
(Figs. 3 and 4). Collagen incubated with ASA and
DHA was not completely soluble in cyanogen bro-
mide. Concentration of samples loaded was adjusted
by the estimation of hydroxyproline. It may be seen
from peptide maps that extensive crosslinking of col-
lagen resulted in a decrease in low molecular weight
fragments and an increase in high molecular weight
fragments. The high molecular weight fragments
failed to penetrate the separating gel.
Incubation of collagen with AGEs also resulted in
decreased digestibility by pepsin. After 2 weeks of
Fig. 2. Pepsin solubility of collagen samples incubated with de-
hydroascorbic acid (DHA) (20 mM) for 4 weeks. Except ASA
all other constituents are the same as in Fig. 1.
Fig. 1. Pepsin solubility of collagen (COL) samples incubated
with ascorbic acid (ASA) (20 mM) for 4 weeks. A, control; B,
COL+ASA; C, COL+ASA+mannitol (100 mM); D, COL+A-
SA+benzoate (100 mM); E, COL+ASA+catalase (25 Wg/ml); F,
COL+ASA+EDTA (2 mM); G, COL+ASA+glutathione (20
mM); H, COL+ASA+aminoguanidine (20 mM).
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incubation in 1.0 mg/ml AGE-BSA about 36% re-
duction in pepsin solubility of collagen samples was
noted compared to control (data not shown). The
extent of crosslinking was increased when the incu-
bation period was prolonged. After 6 weeks the pep-
sin solubility of collagen samples incubated with
AGEs showed 48% reduction (Fig. 5). These results
were compared with collagen incubated with glucose.
It was observed that the rate of increase in crosslink-
ing was relatively slow in collagen incubated with
glucose, compared to collagen incubated with
AGEs. After 2 weeks of incubation collagen incu-
bated in AGEs was about 74% soluble whereas col-
lagen incubated with glucose was more than 80%
soluble in pepsin (data not shown). However when
the incubation period was prolonged, the extent of
crosslinking was increased in glucose incubated sam-
ples. The major di¡erence observed between AGEs-
and glucose-induced crosslinking was the signi¢cance
of free radicals and oxidation reactions. It may be
seen from Fig. 5 that catalase, EDTA and benzoate
showed almost complete inhibition of glucose-in-
duced crosslinking of collagen, whereas in the case
of AGEs-induced crosslinking, no signi¢cant inhibi-
tion by free radical scavengers was noted. Amino-
guanidine and aspirin showed complete prevention
of crosslinking induced by both glucose and AGEs.
These observations were further con¢rmed by the
cyanogen bromide peptide maps. It may be seen
from Figs. 6 and 7 that the increased crosslinking
Fig. 4. Cyanogen bromide peptide maps of collagen samples in-
cubated with dehydroascorbic acid (DHA) (20 mM) for 4 weeks.
Except ASA all other constituents are the same as in Fig. 3.
Fig. 3. Cyanogen bromide peptide maps of collagen (COL)
samples incubated with ascorbid acid (ASA) (20 mM) for
4 weeks. Lane 1, control; 2, COL+ASA; 3, COL+ASA+manni-
tol (100 mM); 4, COL+ASA+benzoate (100 mM); 5, COL+A-
SA+EDTA (2 mM); 6, COL+ASA+glutathione (20 mM); 7,
COL+ASA+aminoguanidine (20 mM).
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of collagen results in an increase in high molecular
weight fragments and a decrease in low molecular
weight fragments. Extensive crosslinking resulted in
the accumulation of very high molecular weight frag-
ments that failed to penetrate the 10% separating gel.
Fig. 8 shows the concentration-dependent e¡ect of
AGEs on collagen crosslinking. It may be noted
that when the concentration of AGEs is increased
from 1 mg/ml to 10 mg/ml, within 2 weeks collagen
becomes extensively crosslinked and failed to move
beyond the stacking gel.
Tables 1 and 2 show the £uorescence intensity of
collagen samples measured at ex: 370 nm and em:
440 nm. As observed in the crosslinking studies, the
increased £uorescence intensity observed in collagen
incubated with glucose was prevented by free radical
scavengers (Table 1), whereas in the samples incu-
bated with AGEs (Table 2) the radical scavengers
failed to inhibit the generation of characteristic £uo-
rescence. It was also noted that glucose-induced £uo-
rescence intensity was slightly higher compared to
that induced by AGEs. Aminoguanidine and aspirin
Fig. 7. Cyanogen bromide peptide map of rat tail tendon colla-
gen (COL) incubated with AGEs for 6 weeks. Lane 1, control;
2, COL+AGEs; 3, COL+AGEs+EDTA (5 mM); 4, COL+A-
GEs+mannitol (100 mM); 5, COL+AGEs+aminoguanidine (50
mM).
Fig. 6. Cyanogen bromide peptide map of rat tail tendon colla-
gen (COL) incubated with AGEs for 2 weeks. Lane 1, control ;
2, COL+AGEs+benzoate (100 mM); 3, COL+AGEs+EDTA
(5 mM); 4, COL+AGEs+mannitol (100 mM); 5, COL+AGEs;
6, COL+AGEs+aminoguanidine (50 mM); 7, COL+AGEs+as-
pirin (20 mM).
Fig. 5. Pepsin solubility of collagen (COL) incubated with
AGEs or glucose (A/G) under di¡erent conditions for 6 weeks.
A, control; B, COL+A/G; C, COL+A/G+catalase (20 Wg/ml);
D, COL+A/G+EDTA (5 mM); E, COL+A/G+benzoate (100
mM); F, COL+A/G+aminoguanidine (50 mM); G, COL+A/
G+aspirin (20 mM).
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showed complete prevention of £uorescence observed
in both incubations.
Enzyme-linked immunoassays revealed crossreac-
tivity between antibody raised against AGE-RNase
and ASA/DHA reacted collagen. The amount of
AGEs formed in collagen samples incubated with
ASA and DHA was almost similar after 4 weeks of
incubation (Tables 3 and 4). A 5-fold increase in
AGEs content was observed in both samples. Radi-
cal scavengers e⁄ciently inhibited the formation of
AGEs in collagen incubated with ASA. Glutathione,
EDTA and aminoguanidine were most e¡ective. As
observed in the previous experiments, the inhibitory
e¡ect of radical scavengers was less pronounced in
collagen incubated with DHA. Mannitol, benzoate,
EDTA and catalase showed more than 60% inhibi-
tion in the AGEs formation in collagen incubated
with ASA, whereas in the samples incubated with
DHA the percentage inhibition was only about 20%.
The amount of AGEs present in collagen incu-
bated with AGE-BSA, as measured by ELISA, is
given in Table 5. Compared to control, collagen in-
cubated with 1.0 mg AGE-BSA for 6 weeks showed
more than 2-fold increase in the accumulation of
AGE-collagen. A slight increase in AGEs content
was observed in collagen incubated with glucose (Ta-
ble 6) compared to collagen incubated with AGEs.
The formation of AGEs in samples incubated with
glucose was e¡ectively prevented by free radical scav-
engers, whereas in the samples incubated with AGEs
no inhibition was observed. Both aminoguanidine
Table 3
AGEs content in collagen incubated with ascorbic acid (20
mM) for 4 weeks
AGEs U/Wg hydroxyproline
Control 3.80 þ 0.3
COL+ASA 15.2 þ 1.4
COL+ASA+mannitol (100 mM) 8.30 þ 0.7
COL+ASA+benzoate (100 mM) 7.40 þ 0.6
COL+ASA+catalase (25 Wg/ml) 7.60 þ 0.7
COL+ASA+EDTA (2 mM) 5.60 þ 0.4
COL+ASA+glutathione (20 mM) 4.50 þ 0.4
COL+ASA+AMG (20 mM) 4.00 þ 0.3
COL, collagen; AMG, aminoguanidine.
Table 2
Fluorescence intensity of collagen samples incubated with
AGEs
Fluorescence AU/Wg
hydroxyproline
Control 18.6 þ 1.8
COL+AGEs 53.6 þ 5.3
COL+AGEs+mannitol (100 mM) 52.4 þ 5.2
COL+AGEs+catalase (20 Wg/ml) 51.6 þ 5.1
COL+AGEs+EDTA (5 mM) 54.7 þ 5.2
COL+AGEs+AMG (50 mM) 21.4 þ 2.0
COL+AGEs+ASP (20 mM) 24.6 þ 2.3
Values are mean þ S.D. of three individual experiments.
COL, collagen; AMG, aminoguanidine; ASP, aspirin.
Table 1
Fluorescence intensity of collagen samples incubated with glu-
cose
Fluorescence AU/Wg
hydroxyproline
Control 19.2 þ 1.4
COL+glucose (250 mM) 83.6 þ 8.1
COL+glucose+catalase (20 Wg/ml) 21.6 þ 2.1
COL+glucose+mannitol (100 mM) 24.5 þ 2.2
COL+glucose+EDTA (5 mM) 22.1 þ 2.0
COL+glucose+AMG (50 mM) 24.5 þ 2.0
COL+glucose+ASP (20 mM) 21.6 þ 2.0
Values are mean þ S.D. of three individual experiments.
COL, collagen; AMG, aminoguanidine; ASP, aspirin.
Fig. 8. Cyanogen bromide peptide map of rat tail tendon colla-
gen (COL) incubated with increasing concentrations of AGEs
for 2 weeks. Lane 1, control; 2, COL+AGEs (500 Wg/ml); 3,
COL+AGEs (1 mg/ml); 4, COL+AGEs (10 mg/ml).
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and aspirin prevented the accumulation of AGEs in
both incubations.
4. Discussion
The present study clearly indicates that soluble
AGEs directly stimulate the crosslinking of collagen
in vitro. A number of reports from di¡erent labora-
tories have almost con¢rmed the potential role of
AGEs in the development of complications in diabe-
tes [27,28]. However, an understanding of the molec-
ular mechanisms involved in glucose-induced cross-
linking of collagen in diabetes is still lacking.
Although a close association between AGEs and
the crosslinking of collagen in diabetes has already
been recognized, the interrelationship between them
is not properly understood. It is not certain whether
AGEs are the cause or consequence or both of col-
lagen crosslinking. One key proposition made is that
AGEs are the crosslinks that are formed as a result
of glycation i.e. AGEs are the intra- or intermolecu-
lar structural entities that are responsible for the in-
creased stability of collagen observed in diabetes.
The present work, for the ¢rst time, demonstrates
that AGEs could be the cause of collagen crosslink-
ing, even in the absence of free glucose. Moreover
the work also provides a direct evidence for the in-
volvement of glucose or glucose-derived products in
the crosslinking of collagen. In a recent report Vlas-
sara et al. [29] have shown that the intravenous ad-
ministration of AGEs duplicated many of the tissue
damages of diabetes in normal rats. Their experiment
provides a direct evidence for the involvement of
AGEs in the development of diabetic complications.
Similarly the present work strongly supports the di-
rect involvement of soluble AGEs in the crosslinking
of collagen.
An important observation made in the present
study was that free radical scavengers and the metal
chelator EDTA failed to inhibit AGEs-induced
crosslinking of collagen, whereas the crosslinking
studies carried out on collagen with glucose, in this
study and earlier reports, have shown considerable
inhibition by free radical scavengers and metal che-
lators [15,16]. Similarly ASA- and DHA-induced
crosslinking of collagen was also prevented by radi-
cal scavengers. The discovery that free radical scav-
engers and metal chelator exert only partial inhibi-
tion on AGEs formation from DHA suggests that
DHA could directly induce AGEs formation and
crosslinking of collagen. The partial inhibitory e¡ect
of free radical scavengers on DHA-induced AGEs
formation observed in this study is in contrast to
the earlier report by Monnier et al. [30]. They have
observed almost complete prevention of pentosidine
Table 6
The level of AGEs measured in collagen samples incubated
with glucose (250 mM)
AGEs U/Wg hydroxyproline
Control 3.2 þ 0.3
COL+glucose 9.6 þ 0.9
COL+glucose+catalase (20 Wg/ml) 4.2 þ 0.4
COL+glucose+mannitol (100 mM) 3.6 þ 0.3
COL+glucose+EDTA (5 mM) 3.8 þ 0.3
COL+glucose+AMG (50 mM) 3.2 þ 0.3
COL+glucose+ASP (20 mM) 3.1 þ 0.3
Values are mean þ S.D. of three individual experiments.
COL, collagen; AMG, aminoguanidine; ASP, aspirin.
Table 5
The level of AGEs measured in collagen samples incubated
with AGE-BSA
AGEs U/Wg hydroxyproline
Control 3.1 þ 0.3
COL+AGEs 8.3 þ 0.9
COL+AGEs+catalase (20 Wg/ml) 8.1 þ 0.9
COL+AGEs+mannitol (100 mM) 8.2 þ 0.9
COL+AGEs+EDTA (5 mM) 8.6 þ 0.8
COL+AGEs+AMG (50 mM) 4.1 þ 0.4
COL+AGEs+ASP (20 mM) 3.8 þ 0.3
Values are mean þ S.D. of three individual experiments.
COL, collagen; AMG, aminoguanidine; ASP, aspirin.
Table 4
AGEs content in collagen incubated with dehydroascorbic acid
(DHA) (20 mM) for 4 weeks
AGEs U/Wg hydroxyproline
Control 3.60 þ 0.3
COL+DHA 15.6 þ 1.6
COL+DHA+mannitol (100 mM) 11.7 þ 1.2
COL+DHA+benzoate (100 mM) 12.3 þ 1.3
COL+DHA+catalase (25 Wg/ml) 10.2 þ 1.2
COL+DHA+EDTA (2 mM) 9.80 þ 1.0
COL+DHA+glutathione (20 mM) 8.70 þ 0.9
COL+DHA+AMG (20 mM) 4.80 þ 0.4
COL, collagen; AMG, aminoguanidine.
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formation by DHA under antioxidative conditions.
As suggested by Monnier et al. [30] it is likely that
DHA could spontaneously degrade to 2,3 diketogul-
onate and xylosone, which are considered as potent
glycating agents even under antioxidative conditions
[30,31]. The radical scavengers used in this study may
not be e⁄cient in preventing the spontaneous frag-
mentation of DHA.
AGEs-induced crosslinking of collagen observed in
this study was totally independent of free radicals
and oxidation reactions. Though a number of in vi-
tro experiments [15,16,32] have proved beyond doubt
the critical role of metal catalysts and oxidation re-
actions in glucose-mediated crosslinking of collagen,
a few questions remain unanswered. First, the se-
quence of the reactions, glycation versus oxidation,
is uncertain. Second, it is well documented that the
autoxidation of free glucose or Amadori products,
which is proposed to play the key role in glucose-
induced crosslinking, leads to formation of both re-
active oxygen species and reactive carbonyl com-
pounds [33,34]. Reports on the inhibition of cross-
linking by free radical scavengers con¢rm the role of
free radicals in glucose-induced crosslinking of colla-
gen. However, the fate of reactive carbonyls under
these conditions is unknown. It is not clear whether
both the reactive radicals and reactive carbonyls ex-
ert a combined e¡ect or a synergistic e¡ect on the
crosslinking of collagen. It may be noted that both
radical scavengers and agents that block the carbonyl
groups (aminoguanidine) have been reported to in-
hibit glucose-induced crosslinking of collagen [9,16].
Recent report by Elgawish et al. [35] have implicated
the role of hydrogen peroxide in crosslinking. It was
observed that incubation of collagen with Amadori
product and hydrogen peroxide results in the accel-
eration of collagen crosslinking, whereas the same
incubation in the absence of Amadori product fails
to induce crosslinking, thereby suggesting the neces-
sity of sugar-derived products, in addition to hydro-
gen peroxide, in glucose-induced crosslinking. Re-
sults obtained in the present study also support this
notion. The observation that the crosslinking of col-
lagen by AGEs remained uninhibited, even in the
presence of free radical scavengers and metal chela-
tor, supports the possibility that the reactive carbon-
yl compounds (i.e. AGEs) are capable of inducing
collagen crosslinking even under antioxidative condi-
tions. From these observations we may propose that
the reactive end products formed, perhaps by the
oxidative reactions catalyzed by metal ions, during
the late stage of Maillard reaction could directly in-
duce collagen crosslinking even under antioxidative
conditions.
Although antioxidants and metal chelators failed
to inhibit AGEs-induced crosslinking of collagen,
aminoguanidine and aspirin signi¢cantly inhibited
the crosslinking process. Aminoguanidine is an agent
that blocks the carbonyl groups of intermediates
formed during glycation [36], whereas aspirin is an
agent that speci¢cally blocks the amino groups [37].
The inhibitory e¡ects of these two compounds sug-
gest that an amino and carbonyl group interaction
may play a role in AGEs-induced collagen crosslink-
ing. This notion receives further support from the
immunological estimation of AGEs. An increased
content of AGEs in collagen samples incubated
with AGEs suggests the binding of soluble AGEs
to collagen. The inhibitory e¡ect of aminoguanidine
and aspirin supports the notion that both aminogu-
anidine and aspirin interfere with the binding proc-
ess.
It may be suggested from the present study that
prolonged hyperglycemia, in combination with in-
creased oxidative stress, actively catalyze the forma-
tion and accumulation of reactive advanced glyca-
tion products. Reversal of hyperglycemia may not
e¡ectively reverse the increased accumulation of
AGEs, which continue to damage tissues. It appears
that antioxidants, like vitamin E, curcumin and taur-
ine may prove e¡ective in the prevention of diabetic
complications rather than as therapeutic agents.
Antiglycating agents aminoguanidine and aspirin
may be better therapeutic agents. Since a concentra-
tion-dependent e¡ect of AGEs on collagen crosslink-
ing was noted in this study, it may also be suggested
that the greater the concentration of AGEs in diabe-
tes, the severe will be the damage.
In conclusion, the results obtained from the
present study indicate that soluble advanced glyca-
tion products may directly stimulate the crosslinking
of collagen. The e¡ect of AGEs on collagen cross-
linking is independent of the presence or absence of
oxygen radicals. It may be hypothesized that glucose
in the presence of oxygen radicals, interacts with
proteins to form highly reactive end products called
BBADIS 61748 21-8-98
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AGEs. These AGEs, once formed, could induce
crosslinking of collagen even in the absence of both
glucose and oxygen.
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